188 related articles for article (PubMed ID: 32807016)
1. RGD peptide-mediated liposomal curcumin targeted delivery to breast cancer cells.
Mahmoudi R; Ashraf Mirahmadi-Babaheidri S; Delaviz H; Fouani MH; Alipour M; Jafari Barmak M; Christiansen G; Bardania H
J Biomater Appl; 2021 Feb; 35(7):743-753. PubMed ID: 32807016
[TBL] [Abstract][Full Text] [Related]
2. Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells.
Mahmoudi R; Hassandokht F; Ardakani MT; Karimi B; Roustazadeh A; Tarvirdipour S; Barmak MJ; Nikseresht M; Baneshi M; Mousavizadeh A; Shirazi MS; Alipour M; Bardania H
J Biomater Appl; 2021 Mar; 35(8):1005-1018. PubMed ID: 33283585
[TBL] [Abstract][Full Text] [Related]
3. RGD-decorated nanoliposomes for combined delivery of arsenic trioxide and curcumin to prostate cancer cells.
Khosravani F; Amiri F; Mahmoudi R; Morshedi D; Kobarfard F; Alipour M; Hosseini E; Bardania H
Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; 397(4):2347-2357. PubMed ID: 37831114
[TBL] [Abstract][Full Text] [Related]
4. Injectable and
Li R; Lin Z; Zhang Q; Zhang Y; Liu Y; Lyu Y; Li X; Zhou C; Wu G; Ao N; Li L
ACS Appl Mater Interfaces; 2020 Apr; 12(15):17936-17948. PubMed ID: 32208630
[TBL] [Abstract][Full Text] [Related]
5. In vitro study of the cytotoxicity of thymoquinone/curcumin fluorescent liposomes.
Fahmy HM
Naunyn Schmiedebergs Arch Pharmacol; 2019 Nov; 392(11):1465-1476. PubMed ID: 31377882
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-human serum albumin nanoparticles decorated with PDL1 binding peptide for targeting PDL1-expressing breast cancer cells.
Hasanpoor Z; Mostafaie A; Nikokar I; Hassan ZM
Int J Biol Macromol; 2020 Sep; 159():137-153. PubMed ID: 32335119
[TBL] [Abstract][Full Text] [Related]
7. Liposomes coated with thiolated chitosan as drug carriers of curcumin.
Li R; Deng L; Cai Z; Zhang S; Wang K; Li L; Ding S; Zhou C
Mater Sci Eng C Mater Biol Appl; 2017 Nov; 80():156-164. PubMed ID: 28866151
[TBL] [Abstract][Full Text] [Related]
8. Delivery of folic acid-modified liposomal curcumin for targeted cervical carcinoma therapy.
Wang WY; Cao YX; Zhou X; Wei B
Drug Des Devel Ther; 2019; 13():2205-2213. PubMed ID: 31308632
[No Abstract] [Full Text] [Related]
9. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
10. Curcumin-loaded mixed micelles: preparation, optimization, physicochemical properties and cytotoxicity in vitro.
Duan Y; Wang J; Yang X; Du H; Xi Y; Zhai G
Drug Deliv; 2015 Jan; 22(1):50-7. PubMed ID: 24417664
[TBL] [Abstract][Full Text] [Related]
11. Novel tumor-targeting, self-assembling peptide nanofiber as a carrier for effective curcumin delivery.
Liu J; Liu J; Xu H; Zhang Y; Chu L; Liu Q; Song N; Yang C
Int J Nanomedicine; 2014; 9():197-207. PubMed ID: 24399876
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma.
Cheng Y; Zhao P; Wu S; Yang T; Chen Y; Zhang X; He C; Zheng C; Li K; Ma X; Xiang G
Int J Pharm; 2018 Jul; 545(1-2):261-273. PubMed ID: 29730175
[TBL] [Abstract][Full Text] [Related]
13. Discovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug delivery.
Zhao Y; Lin D; Wu F; Guo L; He G; Ouyang L; Song X; Huang W; Li X
Int J Mol Sci; 2014 Sep; 15(10):17565-76. PubMed ID: 25268623
[TBL] [Abstract][Full Text] [Related]
14. Delivery Of Curcumin Nanoliposomes Using Surface Modified With CD133 Aptamers For Prostate Cancer.
Ma Q; Qian W; Tao W; Zhou Y; Xue B
Drug Des Devel Ther; 2019; 13():4021-4033. PubMed ID: 31819373
[TBL] [Abstract][Full Text] [Related]
15. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
Ruttala HB; Ko YT
Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
[TBL] [Abstract][Full Text] [Related]
16. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation.
Jiang K; Shen M; Xu W
Int J Nanomedicine; 2018; 13():2561-2569. PubMed ID: 29731631
[TBL] [Abstract][Full Text] [Related]
17. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
[TBL] [Abstract][Full Text] [Related]
18. Fabrication of a multi-level drug release platform with liposomes, chitooligosaccharides, phospholipids and injectable chitosan hydrogel to enhance anti-tumor effectiveness.
Li R; Lyu Y; Luo S; Wang H; Zheng X; Li L; Ao N; Zha Z
Carbohydr Polym; 2021 Oct; 269():118322. PubMed ID: 34294334
[TBL] [Abstract][Full Text] [Related]
19. A Co-Encapsulation of Coenzyme Q10 and Curcumin in Liposomes Coated with Chitosan (Q10-Cur-Lip-Chi) with Enhanced Solubility and Stability for Good Release Performance and Antioxidative Activity.
Yu L; Chao C; Li Q; Ye S; Lin J; Zhong S; Xuan Q; Xu K; Zhao S
Curr Drug Deliv; 2023; 20(9):1391-1403. PubMed ID: 35786187
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation.
Lu Y; Ding N; Yang C; Huang L; Liu J; Xiang G
J Liposome Res; 2012 Jun; 22(2):110-9. PubMed ID: 22372871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
